Cancer Research KI - Collaborations
To promote research excellence, Cancer Research KI has established strategic alliances at the local, national and international level.
Cancer Research KI also strives to promote translation of research findings, and increase the interface between cancer research and clinic at all levels (incl. patient organisations). We work closely together with partners at both KI and the KUH. KI and KUH are the first institutions in Sweden to be accredited as a Comprehensive Cancer Centre.
Cancer Research KI National Collaboration
Cancer Research KI collaborates with strategic partners nationally including the other Strategic Research Programmes in Cancer in Sweden.
Cancer Research KI International Collaboration
Cancer Research KI manages strategic international collaborations with leading cancer institutes globally.
Cancer Research KI Industry Collaboration
Cancer Research KI serves as single point of entry to the cancer research community at KI and works to strengthen and develop fruitful long-term collaborations in the cancer space between KI and industry.
Cancer Research KI- healthcare collaborations
Karolinska Comprehensive Cancer Centre
Karolinska Institutet and Karolinska University Hospital are the first institutions in Sweden to be accredited as a Comprehensive Cancer Centre by the OECI.
Karolinska University Hospital The Cancer Theme
Within Tema Cancer, patients with some form of malignant tumor disease are investigated, treated and cared for during various stages of their cancer disease. Tema Cancer also conducts a lot of clinical studies in various phases and also treats patients who do not have cancer, i.e. benign conditions in areas such as urology, endocrinology, hematology and coagulation. Tema Cancer operates mainly in Huddinge and Solna, but also has activities within cancer care at Danderyd hospital.
Regional Cancer Center Stockholm - Gotland
Regional Cancer Centres (RCC) in Sweden support the regions to increase cancer care quality and improve the outcomes, as well as increase the efficiency of the use of health care resources throughout the patient pathways.
Personalised Cancer Medicine (PCM) Program
The Personalised Cancer Medicine Program at Karolinska Institutet (KIPCM) is a research initiative with the primary task to strengthen the infrastructure for for local, national and international team science addressing PCM, thereby establishing PCM as a leading treatment concept in academic cancer healthcare in Stockholm.